A Trial to Learn if Different Doses of REGN17092 Are Safe in Healthy Adults
Clinical trial NCT05923424 · COMPLETED
Trial details
- NCT number
- NCT05923424
- Sponsor
- Regeneron Pharmaceuticals
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-11-28
- Primary completion
- 2025-03-04
- Enrollment
- 40
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.